Label: CLINPRO 5000- sodium fluoride paste, dentifrice
- NDC Code(s): 48878-3120-4, 48878-3130-4, 48878-3140-4
- Packager: Solventum US OpCo LLC
- Category: HUMAN PRESCRIPTION DRUG LABEL
DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.
Drug Label Information
Updated April 1, 2024
If you are a healthcare professional or from the pharmaceutical industry please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
-
HIGHLIGHTS OF PRESCRIBING INFORMATION
These highlights do not include all the information needed to use 3MTM ESPETM ClinproTM 5000 Anti-Cavity Toothpaste safely and effectively. See full prescribing information for Clinpro 5000 Anti-Cavity Toothpaste.
3MTM ESPETM Clinpro 5000 1.1% Sodium Fluoride Anti-Cavity Toothpaste for oral use.
Initial U.S. Approval: NoneINDICATIONS AND USAGE
Clinpro 5000 Anti-Cavity Toothpaste is indicated for use as part of a professional program for the prevention and control of dental caries. (1)
DOSAGE AND ADMINISTRATION
- Use once daily in place of conventional toothpaste unless instructed otherwise by a physician or dentist. (2)
- Apply a thin ribbon or pea-sized amount of Clinpro 5000 Anti-Cavity Toothpaste using a soft-bristled toothbrush and brush teeth for at least two minutes. (2)
- After brushing adults should expectorate. Children 6 to 16 years of age should expectorate and rinse mouth thoroughly with water. (2)
DOSAGE FORMS AND STRENGTHS
White toothpaste containing 1.1% sodium fluoride (3)
CONTRAINDICATIONS
Do not use in children under 6 years of age unless recommended by a dentist or physician. (4)
WARNINGS AND PRECAUTIONS
ADVERSE REACTIONS
Allergic reactions and other idiosyncrasies have been rarely reported. (6)
To report SUSPECTED ADVERSE REACTIONS, contact 3M ESPE Dental Products Division at 1-800-634-2249 or www.3MESPE.com, or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch
Revised: 1/2012
-
Table of Contents
FULL PRESCRIBING INFORMATION: CONTENTS*
1 INDICATIONS AND USAGE
2 DOSAGE AND ADMINISTRATION
3 DOSAGE FORMS AND STRENGTHS
4 CONTRAINDICATIONS
5 WARNINGS AND PRECAUTIONS
6 ADVERSE REACTIONS
8 USE IN SPECIFIC POPULATIONS
8.1 Pregnancy
8.3 Nursing Mothers
8.4 Pediatric Use
8.5 Geriatric Use
10 OVERDOSAGE
11 DESCRIPTION
12 CLINICAL PHARMACOLOGY
15 REFERENCES
16 HOW SUPPLIED/STORAGE AND HANDLING
- *
- Sections or subsections omitted from the full prescribing information are not listed.
- 1 INDICATIONS AND USAGE
-
2 DOSAGE AND ADMINISTRATION
• Use once daily in place of conventional toothpaste unless instructed otherwise by a physician or dentist.
• Apply a thin ribbon or pea-sized amount of Clinpro 5000 Anti-Cavity Toothpaste using a soft-bristled toothbrush and brush teeth for at least two minutes.
• After brushing adults should expectorate. Children 6 to 16 years of age should expectorate and rinse mouth thoroughly with water.
• Follow these instructions or use as directed by a dental professional.
- 3 DOSAGE FORMS AND STRENGTHS
- 4 CONTRAINDICATIONS
-
5 WARNINGS AND PRECAUTIONS
• DO NOT SWALLOW. If more than a pea-sized amount of Clinpro 5000 Anti-Cavity Toothpaste is swallowed, contact a medical or dental professional or a poison control center.
• Keep out of reach of children under 6 years of age.
• Repeated ingestion of high levels of fluoride may cause dental fluorosis. For this reason, use in children with developing dentition requires special supervision to prevent swallowing. Prescribing dentists and physicians should consider risk of fluorosis when prescribing for use in children less than 6 years of age.
- 6 ADVERSE REACTIONS
-
8 USE IN SPECIFIC POPULATIONS
8.1 Pregnancy
Fluoride crosses the placenta in women and has been measured in cord blood, amniotic fluid, and serum of newborn children, but without a consistent correlation to maternal serum fluoride levels.1,2 There are no data to indicate an increased susceptibility to fluorosis during pregnancy. Developmental studies were conducted by the National Toxicology Program, with sodium fluoride administered in the drinking water to pregnant rats and rabbits. No developmental toxicity was observed, even at doses that caused maternal toxicity. The No Adverse Effect Levels were about 29 mg/kg-day and 27 mg/kg-day for rabbits and rats, respectively.3 There is no conclusive evidence of fluoride developmental effects in humans.1,2
The Institute of Medicine established a fluoride Upper Limit of 10 mg/day for pregnant women.2
Prescribing physicians and dentists should consider total fluoride exposure (dental care plus food, water and other sources) when prescribing the product for use in pregnant women or women who may become pregnant.
8.3 Nursing Mothers
An extremely small proportion of fluoride in drinking water is transferred to breast milk. The Institute of Medicine established a fluoride Upper Limit of 10 mg/day for nursing women.2 Prescribing physicians and dentists should consider total fluoride exposure (dental care plus food, water and other sources) when prescribing the product for use in women who are nursing.
8.4 Pediatric Use
The primary adverse effects of fluoride are fluorosis of dental enamel and of the skeleton; these effects occur at exposures below those associated with other adverse health effects. The population most at risk for dental fluorosis is children during the period of tooth formation, i.e. from birth to 8 years of age. For this population, the Institute of Medicine established Fluoride Upper Limits of intake based on the risk of dental fluorosis. In populations with permanent dentition, skeletal fluorosis is the greatest risk from excessive fluoride. For this population the Institute of Medicine (IOM) established Fluoride Upper Limits based on the risk of skeletal fluorosis.2
Population IOM Fluoride Upper Limit Infants 0-6 months old 0.7 mg/day Infants 7-12 months old 0.9 mg/day Children 1-3 years old 1.3 mg/day Children 4-8 years old 2.2 mg/day Children > 8 years old 10 mg/day Prescribing physicians and dentists should consider total fluoride exposure (dental care plus food, water and other sources) when prescribing the product for use in children.
-
10 OVERDOSAGE
Ingestion of large amounts of fluoride may result in abdominal pain, stomach upset, nausea, vomiting, and diarrhea. These symptoms may occur at overdosages of 5 mg/kg of body weight. Fluoride doses of 16 mg/kg have been fatal.
Treatment Recommendations for Overdose of Clinpro 5000 Anti-Cavity Toothpaste4 Ingested fluoride dose Amount for 10 kg (22 pound) child* Recommended action to take Less than 5 mg/kg This equals less than ½ ounce (or less than 3 teaspoons). Do not induce vomiting. Give 1-2 glasses of milk and observe for symptoms of stomach upset. If symptoms persist more than a few hours, seek medical attention or contact a poison control center. 5 mg/kg or more This equals about ½ ounce (about 1 tablespoon) or more. Do not induce vomiting. Give 1-2 glasses of milk and seek medical attention or contact a poison control center. 15 mg/kg This equals 1 ounce or ¼ of the tube. Seek immediate medical attention. Do not induce vomiting. Give 1-2 glasses of milk. *The amount to reach the fluoride dose will be proportionately larger with older children and adults.
A thin ribbon or pea-sized amount of Clinpro 5000 Anti-Cavity Toothpaste weighs approximately 0.3 g and contains approximately 1.5 mg of fluoride ion. A 4 oz. tube contains 564 mg of fluoride ion. -
11 DESCRIPTION
Clinpro 5000 1.1% Sodium Fluoride Anti-Cavity Toothpaste is a self-applied fluoride dentifrice for the prevention of dental caries. Each gram contains 5 mg of fluoride ion in a neutral pH base, consisting of water, sorbitol, hydrated silica, glycerin, polyethylene-polypropylene glycol, flavor, polyethylene glycol, sodium lauryl sulfate, titanium dioxide, carboxymethyl cellulose, sodium saccharin and tri-calcium phosphate.
-
12 CLINICAL PHARMACOLOGY
Clinpro 5000 1.1% Sodium Fluoride Anti-Cavity Toothpaste aids in the prevention of tooth decay. Fluoride delivered from Clinpro 5000 inhibits the demineralization of sound teeth and enhances the remineralization (i.e., repair) of demineralized teeth. During tooth brushing, fluoride is taken up by teeth and dental plaque. Fluoride is taken up with calcium and phosphate by demineralized teeth resulting in an improved tooth structure than contains more fluoride and less carbonate than naturally occurring tooth structure and is more resistant to acid challenge. Additionally, calcium fluoride is formed on the crystal structure of teeth. As the pH of the mouth drops, fluoride is released from calcium fluoride and aids in the remineralization of teeth. Fluoride taken up into plaque alters the activity of cariogenic bacteria. Fluoride inhibits the process by which cariogenic bacteria metabolize carbohydrates resulting in less acid and adhesive polysaccharide production by the bacteria.
-
15 REFERENCES
- National Research Council. Fluoride in drinking water: A scientific review of EPA's standards; National Academies Press 2006.
- IOM. Dietary Reference Intakes: The essential guide to nutrient requirements. National Academies Press 2006.
- Heindel JJ, et al. Developmental toxicity evaluation of sodium fluoride administered to rats and rabbits in drinking water. Fundam Appl Toxicol 1996;30(2):162-177.
- Poisindex. Toxicologic Management – Fluoride. Thomson Micromedex.
-
16 HOW SUPPLIED/STORAGE AND HANDLING
Clinpro 5000 Anti-Cavity Toothpaste is supplied as a white dentifrice paste in a 4 oz. (113 gm) plastic tube (NDC 48878-3120-4, Vanilla Mint Flavor; NDC 48878-3130-4 Spearmint Flavor; NDC 48878-3140-4 Bubble Gum Flavor).
Storage
This product is designed to be stored and used at room temperature. Do not freeze or expose to extreme heat. See outer package for expiration date.
Manufactured for:
3M ESPE
Dental Products
2510 Conway Avenue
St. Paul, MN 55144-1000 USA
Revision date: 01/11/2012Rx Only
3M, ESPE, and Clinpro are trademarks of 3M or 3M Deutschland GmbH.
© 3M 2016. All rights reserved. - PRINCIPAL DISPLAY PANEL
- PRINCIPAL DISPLAY PANEL
- PRINCIPAL DISPLAY PANEL
-
INGREDIENTS AND APPEARANCE
CLINPRO 5000
sodium fluoride paste, dentifriceProduct Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:48878-3120 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength sodium fluoride (UNII: 8ZYQ1474W7) (fluoride ion - UNII:Q80VPU408O) fluoride ion 5 mg in 1 g Inactive Ingredients Ingredient Name Strength Water (UNII: 059QF0KO0R) Sorbitol (UNII: 506T60A25R) Silicon Dioxide (UNII: ETJ7Z6XBU4) Glycerin (UNII: PDC6A3C0OX) Polyethylene Glycol, Unspecified (UNII: 3WJQ0SDW1A) Sodium Lauryl Sulfate (UNII: 368GB5141J) Titanium Dioxide (UNII: 15FIX9V2JP) Carboxymethylcellulose Sodium (UNII: K679OBS311) Saccharin Sodium (UNII: SB8ZUX40TY) Tricalcium Phosphate (UNII: K4C08XP666) Product Characteristics Color Score Shape Size Flavor MINT (MINT) Imprint Code Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:48878-3120-4 1 in 1 BOX 01/01/2009 1 113 g in 1 TUBE; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 01/01/2009 CLINPRO 5000
sodium fluoride paste, dentifriceProduct Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:48878-3130 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength sodium fluoride (UNII: 8ZYQ1474W7) (fluoride ion - UNII:Q80VPU408O) fluoride ion 5 mg in 1 g Inactive Ingredients Ingredient Name Strength Water (UNII: 059QF0KO0R) Sorbitol (UNII: 506T60A25R) Silicon Dioxide (UNII: ETJ7Z6XBU4) Glycerin (UNII: PDC6A3C0OX) Polyethylene Glycol, Unspecified (UNII: 3WJQ0SDW1A) Sodium Lauryl Sulfate (UNII: 368GB5141J) Titanium Dioxide (UNII: 15FIX9V2JP) Carboxymethylcellulose Sodium (UNII: K679OBS311) Saccharin Sodium (UNII: SB8ZUX40TY) Tricalcium Phosphate (UNII: K4C08XP666) Product Characteristics Color Score Shape Size Flavor SPEARMINT (SPEARMINT) Imprint Code Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:48878-3130-4 1 in 1 BOX 10/15/2010 1 113 g in 1 TUBE; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 10/15/2010 CLINPRO 5000
sodium fluoride paste, dentifriceProduct Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:48878-3140 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength sodium fluoride (UNII: 8ZYQ1474W7) (fluoride ion - UNII:Q80VPU408O) fluoride ion 5 mg in 1 g Inactive Ingredients Ingredient Name Strength Water (UNII: 059QF0KO0R) Sorbitol (UNII: 506T60A25R) Silicon Dioxide (UNII: ETJ7Z6XBU4) Glycerin (UNII: PDC6A3C0OX) Polyethylene Glycol, Unspecified (UNII: 3WJQ0SDW1A) Sodium Lauryl Sulfate (UNII: 368GB5141J) Titanium Dioxide (UNII: 15FIX9V2JP) Carboxymethylcellulose Sodium (UNII: K679OBS311) Saccharin Sodium (UNII: SB8ZUX40TY) Tricalcium Phosphate (UNII: K4C08XP666) Product Characteristics Color Score Shape Size Flavor BUBBLE GUM (BUBBLE GUM) Imprint Code Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:48878-3140-4 1 in 1 BOX 01/07/2011 1 113 g in 1 TUBE; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 01/07/2011 Labeler - Solventum US OpCo LLC (801390852)
